Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Zosano Pharma Corporation

TRADE

NASDAQ: ZSANHealthcare / Biotechnology / USA
4.12+0.10+2.49%Vol 54 6971Y Perf -75.74%
Oct 19th, 2018 15:59
BID4.10 ASK4.12
Open4.02 Previous Close4.02
Pre-Market- After-Trading-
 - -%  - -%
Target Price
19.00 
Analyst Rating
Strong Buy 1.00
Potencial %
361.17 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)49 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.31 
Earnings Date
8th Nov 2018

Today's Price Range

4.024.14

 

52wk Range

3.6125.70

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
3.00%
3 Months
-5.94%
6 Months
-2.83%
1 Year
-75.74%
3 Years
-93.27%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ZSAN4.120.10002.49
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.60
Current Ratio 4.70
Long Term Debt to Total Capital 0.12
Total Debt to Equity 0.10
Interest Coverage -43.90
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.33
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.10
Cash Flow Per Share -6.18
Price to Tangible Book1.33
Book Value per Share3.01
Enterprise Value (in ths.)13 854
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-408.56
ROE last 12 Months -110.72
Return on Assets (5Y Avg) -54.83
ROA last 12 Months -80.35
Return on Capital (5Y Avg) -
ROC last 12 Months -95.65
Return on invested Capital Q -40.33
Return on invested Capital Y-234.29
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.75-
Q01 2018--4.16-
Q04 2017-4.80-3.8020.83
Q03 2017-3.00-4.00-33.33
Q02 2017-3.00-3.40-13.33
Q01 2017-6.00-6.80-13.33
Q04 2016-9.00-9.20-2.22
Q03 2016-13.00-10.4020.00
Earnings Per EndEstimateRevision %Trend
3/2018 QR-5.400.00-
6/2018 QR-4.200.00-
12/2018 FY-18.000.00-
12/2018 FY-18.000.00-
Next Report Date8th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume54 697
Shares Outstanding (in ths.)11 970
Trades Count193
Dollar Volume204 585
Avg. Volume607 993
Avg. Weekly Volume59 048
Avg. Monthly Volume99 992
Avg. Quarterly Volume124 576

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

56%44%

Bearish Bullish

74%26%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x